Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P11021 (
BiP
)
2,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study we have explored the endoplasmic reticulum associated events accompanying the maturation of the
tyrosinase-related protein-1
(
TRP-1
) nascent chain synthesized in mouse melanoma cells. We show that
TRP-1
folding process occurs much more rapidly than for tyrosinase, a highly homologous protein, being completed post-translationally by the formation of critical disulfide bonds. In cells pretreated with dithiothreitol (DTT), unfolded
TRP-1
is retained in the endoplasmic reticulum by a prolonged interaction with calnexin and
BiP
before being targeted for degradation. The
TRP-1
chain was able to fold into DTT-resistant conformations both in the presence or absence of alpha-glucosidase inhibitors, but folding occurred through different pathways. During the normal folding pathway,
TRP-1
interacts with calnexin. In the presence of alpha-glucosidase inhibitors, the interaction with calnexin is prevented, with
TRP-1
folding being assisted by
BiP
. In this case, the process has similar kinetics to that of untreated
TRP-1
and yields a compact form insensitive to DTT as well. However, this form has different thermal denaturation properties than the native conformation. We conclude that disulfide bridge burring is crucial for the
TRP-1
export. This suggests that although various folding pathways may complete this process, the native form may be acquired only through the normal unperturbed pathway.
...
PMID:Folding and maturation of tyrosinase-related protein-1 are regulated by the post-translational formation of disulfide bonds and by N-glycan processing. 1091 99